| 11826317 |
Combination therapy with notch and PD-1 or PD-L1 inhibitors |
Mark Harrath Bender, Hong Gao |
2023-11-28 |
| 11564929 |
Combination therapy with Notch and PI3K/mTOR inhibitors for use in treating cancer |
Michele Smith |
2023-01-31 |
| 11298362 |
Combination therapy with Notch and CDK4/6 inhibitors for the treatment of cancer |
Richard Paul Beckmann |
2022-04-12 |
| 10787460 |
(E)-1-(4-(dimethylamino)but-2-enoyl)pyrrolidin-3-yl 4-((3-isopropyl-5-methylpyrazolo[1,5-a]pyrimidin-7-yl)amino)piperidine-1-carboxylate for inhibiting CDK7 |
David Coates, Carlos Montero, David Michael Remick, Yipin Yadav |
2020-09-29 |
| 10688104 |
Combination therapy with Notch and PD-1 or PD-L1 inhibitors |
Mark Harrath Bender, Hong Gao |
2020-06-23 |
| 10450317 |
Notch pathway signaling inhibitor compounds |
Julia Marie Clay, Albert Edge, Philip Arthur Hipskind, John Gill, Helmuth van Es +2 more |
2019-10-22 |
| 9000023 |
Disubstituted phthalazine hedgehog pathway antagonists |
Philip Arthur Hipskind, Takako Wilson (nee Takakuwa) |
2015-04-07 |
| 8273742 |
Disubstituted phthalazine hedgehog pathway antagonists |
Philip Arthur Hipskind, Takako Wilson (nee Takakuwa) |
2012-09-25 |
| 7541344 |
Modulation of survivin expression |
Balkrishen Bhat, Eric E. Swayze |
2009-06-02 |
| 6368828 |
Attenuated and dominant negative variant cDNAs of Stat6: Stat6b and Stat6c |
William LaRochelle, Jacalyn H. Pierce |
2002-04-09 |